Noninvasive testing technology for cancer diagnosis and monitoring has advanced to include liquid biopsy for early detection. Using nothing more than a blood sample, scientists can locate DNA belonging to the tumor, referred to as circulating tumor DNA (ctDNA), and analyze it to diagnose the type of cancer present as well as identify specific characteristics...Continue reading
